146
Participants
Start Date
July 20, 2023
Primary Completion Date
November 30, 2025
Study Completion Date
November 30, 2025
Retatrutide
Administered SC
Placebo
Administered SC
NYU Langone Hospital - Long Island, Mineola
Ospedale San Raffaele, Milan
Centro Cardiologico Monzino, Milan
Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo
Teradan Clinical Trials, LLC, Brandon
Suncoast Clinical Research, Inc., New Port Richey
Prime Health and Wellness/SKYCRNG, Fayette
Clínica nuevas Tecnologías en Diabetes y Endocrinología (NTDE), Seville
Cleveland Clinic, Cleveland
Hospital Clinico de Valencia, Valencia
Hospital Universitario Doctor Peset, Valencia
Indiana University Health University Hospital, Indianapolis
Azienda Ospedaliera Universitaria Pisana, Pisa
Great Lakes Clinical Trials - Ravenswood, Chicago
Victorium Clinical Research - Houston, Houston
Endocrine Ips, Pllc, Houston
Tranquility Research, Webster
University of Colorado Anschutz Medical Campus, Aurora
Care Access - 801 South Power Road, Mesa, Mesa
The Institute for Liver Health II dba Arizona Clinical Trials - Mesa, Chandler
Headlands Research - Scottsdale, Scottsdale
Medical Advancement Centers of Arizona, Tempe
Palm Research Center Tenaya, Las Vegas
Peninsula Research Associates, Rolling Hills Estates
Hope Clinical Research, Inc., Canoga Park
Catalina Research Institute, LLC, Montclair
Centricity Research Brampton Endocrinology, Brampton
Circulate Cardiac & Vascular Centre, Burlington
North York Diagnostic and Cardiac Centre, North York
Stouffville Medical Research Institute Inc., Stouffville
Dr. Anil K. Gupta Medicine Professional Corporation, Toronto
Fadia El Boreky Medicine, Waterloo
Viacar Recherche Clinique, Greenfield Park
Diex Recherche Joliette, Joliette
9109-0126 Quebec Inc., Montreal
Addenbrooke's Hospital, Cambridge
FutureMeds Teesside - Middlefield Centre, Stockton-on-Tees
Royal London Hospital, London
Futuremeds-Newcastle, Newcastle
Vascular Research Team, Salford
North Middlesex Hospital, London
City Hospital, Nottingham University Hospitals NHS Trust, Nottingham
Eli Lilly and Company
INDUSTRY